(Q40126396)

17 September 2017

1 reference

title

Epstein-Barr virus and human disease: immune responses determine the clinical and pathologic expression (English)

1 reference

17 September 2017

Epstein-barr virus and human disease: Immune responses determine the clinical and pathologic expression (English)

1 reference

https://api.crossref.org/works/10.1016/S0046-8177(81)80162-1

12 September 2023

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6269987

12 September 2023

author name string

D. T. Purtilo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6269987

12 September 2023

K. Sakamoto

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6269987

12 September 2023

language of work or name

English

0 references

publication date

1 August 1981

1 reference

full work available at URL

17 September 2017

https://api.elsevier.com/content/article/PII:S0046817781801621?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0046-8177(81)80162-1

https://api.elsevier.com/content/article/PII:S0046817781801621?httpAccept=text/plain

12 September 2023

1 reference

https://api.crossref.org/works/10.1016/S0046-8177(81)80162-1

12 September 2023

1 reference

17 September 2017

volume

12

1 reference

17 September 2017

issue

8

1 reference

17 September 2017

page(s)

677-679

1 reference

Epstein-Barr virus specific diagnostic tests in infectious mononucleosis

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2881%2980162-1

7 January 2021

HLA-restricted T-cell recognition of Epstein–Barr virus-infected B cells

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2881%2980162-1

7 January 2021

Immune and non-immune control of neoplastic development: contrasting effects of host and tumor evolution

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2881%2980162-1

7 January 2021

X-linked lymphoproliferative syndrome registry report

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2881%2980162-1

7 January 2021

Epstein-Barr-virus-induced oncogenesis in immune-deficient individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2881%2980162-1

7 January 2021

Deficient Natural Killer Cell Activity in X-Linked Lymphoproliferative Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2881%2980162-1

7 January 2021

Pathogenesis and phenotypes of an X-linked recessive lymphoproliferative syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2881%2980162-1

7 January 2021

Antibody responses to Epstein-Barr virus in families with the X-linked lymphoproliferative syndrome

7

1 reference

https://api.crossref.org/works/10.1016/S0046-8177(81)80162-1

Immunopathology of infectious mononucleosis and other complications of Epstein-Barr virus infections

12 September 2023

9

1 reference

https://api.crossref.org/works/10.1016/S0046-8177(81)80162-1

Immunodiagnosis and immunopathogenesis of the X-linked recessive lymphoproliferative syndrome

12 September 2023

10

1 reference

https://api.crossref.org/works/10.1016/S0046-8177(81)80162-1

12 September 2023

Identifiers

1 reference

17 September 2017

1 reference